Jilian Golding
Seminars
Thursday 8th October 2026
Panel Discussion: Mobilizing Precision Cancer Care Through the Precision Cancer Consortium to Standardize Testing Pathways & Reduce Access Barriers
9:00 am
- How can multi‑company collaboration accelerate global access to comprehensive genomic profiling, particularly in regions where testing infrastructure and reimbursement remain limited?
- What operational barriers most constrain CGP adoption, and what tools can help standardize processes across health systems?
- How can harmonized testing pathways, shared training resources, and coordinated industry engagement reduce variation in CGP turnaround times and improve diagnostic quality globally?
Wednesday 7th October 2026
Panel Discussion: Bolstering Scalable Commercial Drug-Diagnostic Strategies to Ensure Equitable Solutions for Global Precision Oncology Applications
3:10 pm
- How can biopharma and diagnostics partners truly synchronize drug-CDx launches to avoid misalignment in assay availability, regulatory timing, and clinical adoption across markets?
- What are the biggest barriers to global drug-CDx adoption at launch, and how can they be proactively addressed within commercialization strategies?
- In an increasingly complex global landscape, how can organizations balance the need for standardized CDx strategies with local market realities to achieve equitable patient access?
